HCW Biologics Inc. (HCWB) vs XORTX Therapeutics Inc. (XRTX)
A side-by-side comparison of HCW Biologics Inc. and XORTX Therapeutics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
HCWB
HCW Biologics Inc.
$1.59HealthcareDelayed quote: Oct 6, 2026, 2:32 PM EDT
XRTX
XORTX Therapeutics Inc.
$1.74HealthcareDelayed quote: Oct 6, 2026, 2:38 PM EDT
Total return — HCWB vs XRTX
growth of $100 · dividends reinvested · last 5yHCWB -99.9% (-74.5%/yr)XRTX -98.1% (-54.6%/yr)XRTX compounded faster over this window
Log scale — wide-divergence pair
HCWB XRTX
HCWB vs XRTX: by the numbers
- •HCWB is the larger company ($552749 vs $484571 market cap).
- •Both run net losses; XRTX's is the smaller (0.00% vs -73.22% net margin).
Metrics side by side
Valuation
| Metric | HCWB | XRTX |
|---|---|---|
| P/S ratio | 0.08 | N/A |
| P/B ratio | 0.07 | 0.09 |
Profitability
| Metric | HCWB | XRTX |
|---|---|---|
| Gross margin | 20.00% | 0.00% |
| Operating margin | -20757.65% | 0.00% |
| Net margin | -73.22% | 0.00% |
| ROE | -66.26% | -68.17% |
| ROIC | -41.92% | -71.43% |
Growth (annualized)
| Metric | HCWB | XRTX |
|---|---|---|
| Revenue CAGR (5Y) | -57.90% | N/A |
| Total return CAGR (5Y) | -69.71% | -63.52% |
Frequently asked
- How have HCWB and XRTX total returns compared?
- Over the past 5 years, HCWB delivered -69.71% and XRTX delivered -63.52% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.